| Literature DB >> 28416972 |
Takashi Kaneshiro1,2, Kentaro Yoshida1, Yukio Sekiguchi1, Hiroshi Tada3, Kenji Kuroki1, Keisuke Kuga1, Yoshiyuki Kamiyama2, Hitoshi Suzuki2, Yasuchika Takeishi2, Kazutaka Aonuma1.
Abstract
BACKGROUND: Several studies reported that cavotricuspid isthmus-dependent atrial flutter (typical AFL) frequently coexists with atrial fibrillation (AF); however, the underlying mechanisms have not been fully investigated. This study aimed to reveal the mechanisms of the initiation of typical AFL and the association between typical AFL and AF.Entities:
Keywords: Atrial fibrillation; Catheter ablation; Pulmonary vein firing; Typical atrial flutter
Year: 2016 PMID: 28416972 PMCID: PMC5388043 DOI: 10.1016/j.joa.2016.07.013
Source DB: PubMed Journal: J Arrhythm ISSN: 1880-4276
Baseline characteristics of the study population undergoing first catheter ablation of atrial fibrillation.
| Age (y) | 60.4±11.8 | 57.4±13.9 | 60.5±11.7 |
| Male sex | 129 (84%) | 8 (100%) | 121 (83%) |
| Type of AF: persistent | 58 (38%) | 3 (38%) | 55 (38%) |
| History of AFL | 11 (7%) | 0 (0%) | 11 (8%) |
| LVEF (%) | 65.7±0.1 | 63.9±7.7 | 65.8±9.1 |
| LVDd (mm) | 48.4±5.3 | 50.3±3.7 | 48.3±5.4 |
| LAD (mm) | 38.1±6.9 | 38.1±8.1 | 38.1±6.9 |
| Hypertension | 71 (46%) | 4 (50%) | 67 (46%) |
| Dyslipidemia | 51 (33%) | 3 (38%) | 48 (33%) |
| Diabetes | 26 (17%) | 3 (38%) | 23 (16%) |
| Structural heart disease | 13 (8%) | 0 (0%) | 13 (9%) |
| ABL procedure for AF | |||
| EEPVI | 77 (50%) | 3 (38%) | 74 (51%) |
| EEPVI+roof line±SVC-I | 39 (25%) | 2 (25%) | 37 (25%) |
| EEPVI+roof line±SVC-I+CFAE | 38 (25%) | 3 (38%) | 35 (24%) |
| CTI | 131 (85%) | 8 (100%) | 123 (84%) |
Data are shown as the means±standard deviations or number of patients (%).
AAD=anti-arrhythmic drug; ABL=ablation; AF=atrial fibrillation; AFL=atrial flutter; CFAE=continuous fractionated atrial electrogram; CTI=cavotricuspid isthmus; EEPVI=extensive encircling pulmonary vein isolation; LAD=left atrial diameter; LVDd=left ventricular end-diastolic diameter; LVEF=left ventricular ejection fraction; SVC-I=superior vena cava isolation.
Baseline characteristics of the study population undergoing catheter ablation of typical atrial flutter.
| Age (y) | 59.6 ± 13.9 | 58.2 ± 13.0 | 60.3 ± 14.4 | 0.456 |
| Male sex | 58 (87%) | 19 (83%) | 39 (89%) | 0.492 |
| Body mass index (kg/m2) | 23.2±4.1 | 23.6±2.4 | 23.0±4.8 | 0.716 |
| LVEF (%) | 58.1±10.7 | 59.7±10.4 | 57.2±10.9 | 0.265 |
| LVDd (mm) | 46.6±6.6 | 46.4±6.4 | 46.7±6.7 | 0.703 |
| LAD (mm) | 38.2±6.6 | 40.6±6.1 | 37.0±6.5 | 0.036 |
| Plasma BNP level (ng/L) | 106.2±184.3 | 125.4±108.0 | 96.3±214.4 | 0.062 |
| Creatinine (µmol/L) | 96.08±122.00 | 81.59±86.16 | 103.70±137.25 | 0.668 |
| Hypertension | 25 (37%) | 9 (39%) | 16 (36%) | 0.824 |
| Dyslipidemia | 21 (31%) | 7 (30%) | 14 (32%) | 0.908 |
| Diabetes | 12 (18%) | 3 (13%) | 9 (20%) | 0.453 |
| Structural heart disease | 8 (12%) | 1 (4%) | 7 (16%) | 0.166 |
| Class I AAD before AFL ABL | 36 (54%) | 13 (57%) | 23 (52%) | 0.741 |
| Class III AAD before AFL ABL | 6 (9%) | 3 (13%) | 3 (7%) | 0.397 |
Data are shown as the means±standard deviation or number of patients.
AAD=anti-arrhythmic drug; ABL=ablation; AF=atrial fibrillation; AFL=atrial flutter; BNP=brain natriuretic peptide; LAD=left atrial diameter; LVDd=left ventricular end-diastolic diameter; LVEF=left ventricular ejection fraction.
Fig. 1Representative case of typical atrial flutter initiated by paroxysmal atrial fibrillation following a pulmonary vein firing. Atrial fibrillation was initiated with a left superior pulmonary vein firing (solid arrow) during baseline sinus rhythm and was subsequently converted to typical atrial flutter. AFL=atrial flutter; CS=coronary sinus; HRA=high right atrium; LIPV=left inferior pulmonary vein; LSPV=left superior pulmonary vein.
Fig. 2Representative case of reverse typical atrial flutter initiated with paroxysmal atrial fibrillation following a superior vena cava firing. The baseline rhythm was sinus rhythm after an extensive encircling pulmonary vein isolation. Atrial fibrillation was initiated with a superior vena cava firing during baseline sinus rhythm and was subsequently converted to reverse typical atrial flutter. The solid arrow in the upper panel shows the superior vena cava firing as the initiator of atrial fibrillation. The solid arrows in the lower panel show the clockwise activation sequence along the tricuspid annulus during reverse typical AFL. AFL=atrial flutter; CL=cycle length; CS d=coronary sinus distal; CS p=coronary sinus proximal; HRA=high right atrium; LIPV=right inferior pulmonary vein; LLRA=low lateral right atrium; MLRA=mid lateral right atrium; PPI=post-pacing interval; SVC=superior vena cava.
Detailed electrophysiological findings of the patients with an appearance of typical AFL during first catheter ablation of atrial fibrillation.
| 1 | 65/male | Paroxysmal | SR | AF following RSPV firing |
| 2 | 60/male | Paroxysmal | SR | AF following LIPV firing |
| 3 | 59/male | Persistent | SR | AF following RSPV firing |
| 4 | 68/male | Paroxysmal | SR | AF following SVC firing (after PVI) |
| 5 | 66/male | Persistent | SR | AF following LSPV firing |
| 6 | 25/male | Paroxysmal | SR | AF following LSPV firing |
| 7 | 63/male | Persistent | SR | AF following LSPV firing |
| 8 | 53/male | Paroxysmal | SR | AF following LSPV firing |
AF=atrial fibrillation; AFL=atrial flutter; LIPV=left inferior pulmonary vein; LSPV=left superior pulmonary vein; PVI=pulmonary vein isolation; RSPV=right superior pulmonary vein; SR=sinus rhythm; SVC=superior vena cava.
Fig. 3Kaplan-Meier analysis of freedom from the occurrence of atrial fibrillation after the ablation of typical atrial flutter between the patients with a left atrial diameter of >40 mm and a normal (≤40 mm) left atrial diameter. ABL=ablation; AF=atrial fibrillation; AFL=atrial flutter; LAD=left atrial diameter.